MedPath

Effect of Pala Madakku Thailam (Internal Medicated Oil) on Osteoporosis

Not Applicable
Conditions
Health Condition 1: M818- Other osteoporosis without currentpathological fracture
Registration Number
CTRI/2022/07/044274
Lead Sponsor
ational Institute of Siddha
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Bone Mineral Density T-Score less than â?? 1 will be included.

Exclusion Criteria

1. K/H/O Renal / Hepatic / cardiac disease

2. K/H/O Prolonged glucocorticoid administration

3. K/H/O Genetic or autoimmune disorders

4. All cases of Secondary Osteoporosis including K/H/O Cushingâ??s syndrome, K/H/O Hyperparathyroidism.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The outcome of the study will be assessed by using the <br/ ><br>1. Bone Mineral Density Scan (Peripheral DXA Scan) T Score before and after treatment. <br/ ><br>2. Improvement in Clinical symptoms before and after treatment.Timepoint: Screening - 2 months <br/ ><br>Enrolment - 2 months <br/ ><br>Intervention - 4 months <br/ ><br>Data Analysis - 2 months <br/ ><br>Follow up - 2 months
Secondary Outcome Measures
NameTimeMethod
ILTimepoint: NI
© Copyright 2025. All Rights Reserved by MedPath